Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Udenafil may help hair grow by activating certain stem cells.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Alopecia areata is now understood to be driven by genetic and immune factors.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Targeting CXCL10 may help treat alopecia areata.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New therapies are being developed that target integrin pathways to treat various diseases.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.